Klivira
Request demo

Streamlining Transplant Eligibility Verification for High-Acuity Care

Accurate and timely **transplant eligibility verification** is critical for managing the financial integrity of complex, high-cost transplant care pathways, from evaluation to post-transplant follow-up.

For transplant centers, ensuring continuous patient eligibility and understanding benefit limitations is paramount to preventing costly denials and ensuring seamless access to life-saving treatment. Manual processes often lead to stale data, misinterpretation of complex benefit structures, and missed prior authorization triggers, directly impacting revenue cycles and patient care continuity.

The Unique Challenges of Transplant Eligibility Verification

Transplant care involves extended evaluation periods, high-cost surgical procedures, and lifelong immunosuppressant therapies. This prolonged care continuum amplifies the risk of coverage changes and benefit exhaustion, making robust eligibility verification essential to secure reimbursement for every phase of treatment, including transplant evaluation, the procedure itself, and ongoing immunosuppressants.

Common Failure Points in Manual Transplant Eligibility Workflows

  • Stale eligibility data leading to denials for high-cost infusion medications or advanced imaging during evaluation.
  • Misinterpretation of complex X12 271 responses regarding specific benefit categories for transplant-related services or drug formularies.
  • Missed prior authorization requirements for transplant evaluation workups or specific immunosuppressants, triggering downstream denials.
  • Failure to identify secondary coverage or coordination of benefits (COB) for long-term transplant patients, impacting claim submission.
  • Lack of visibility into benefit exhaustion for specific categories, such as physical therapy post-transplant or mental health support.

Klivira's Automated Approach to Transplant Eligibility

Klivira automates multi-channel eligibility queries, submitting X12 270 transactions via clearinghouses and querying FHIR Coverage endpoints for supported payers. This ensures comprehensive benefit detail capture, including plan type, deductible status, copay/coinsurance, and in-network status, all critical for transplant financial counseling.

Key Automation Features for Transplant Revenue Cycle

  • **PA Workflow Gating:** Eligibility checks automatically initiate prior authorization workflows when PA is identified for transplant evaluation, procedures, or high-cost immunosuppressants.
  • **Re-verification Logic:** Automated re-verification closer to the date of service for scheduled transplant procedures or high-cost infusions, mitigating stale data risks.
  • **Benefit Exhaustion Tracking:** Monitors utilization against caps for benefit categories like physical therapy or mental health, crucial for long-term transplant recovery.
  • **EMR Write-Back:** Normalized eligibility data is written back to the EMR as a Coverage resource update or structured note, ensuring clinical and financial teams have real-time visibility.
  • **Compliance with Standards:** Leverages X12 270/271 and FHIR Coverage resources, aligning with industry standards and CMS-0057-F Patient Access API requirements.

Impact on Transplant Revenue Cycle and Patient Access

By addressing critical failure modes like stale eligibility and misinterpretation of benefit details, Klivira significantly reduces eligibility-related claim denials, a meaningful portion of all denials as highlighted by the CAQH Index. This proactive approach ensures financial clarity for patients and optimizes the revenue cycle for transplant centers, supporting uninterrupted care.

Frequently asked questions

How does Klivira handle eligibility verification for patients with multiple transplant-related insurance plans?

Klivira's system automatically identifies and processes secondary coverage, including Medicare-secondary-payer status and coordination of benefits requirements, ensuring all applicable coverages are accounted for before service. This prevents missed reimbursement opportunities common in complex transplant cases.

Can Klivira verify eligibility for specific high-cost immunosuppressants or infusion meds?

Yes, Klivira's normalized eligibility model parses detailed benefit information from X12 271 responses or FHIR Coverage data, often identifying specific PA requirements or benefit limitations for drug categories common in transplant care. This proactively flags potential issues before medication dispensing.

How does Klivira ensure eligibility data remains current for long transplant evaluation periods?

For high-cost services like transplant evaluations or procedures scheduled in advance, Klivira employs re-verification logic to automatically re-check eligibility closer to the date of service. This helps catch mid-period coverage changes that could otherwise lead to denials.

What if a payer doesn't support X12 EDI or FHIR for eligibility?

While Klivira prioritizes automated X12 270/271 and FHIR queries, we acknowledge that some payers remain manual-only. For these instances, Klivira's platform can be configured to support payer-portal automation where feasible, ensuring comprehensive coverage across diverse payer landscapes.

Does Klivira track benefit limits for post-transplant services like physical therapy?

Yes, Klivira's benefit-exhaustion tracking monitors running utilization against visit or cost caps for specific benefit categories, such as physical therapy, occupational therapy, or mental health support. This provides clear visibility into remaining benefits, preventing unexpected patient liabilities and denials.

Related coverage

Other transplant prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo